EasySep™小鼠B细胞分离试剂盒

未接触小鼠B细胞的免疫磁阴性分离

产品号 #(选择产品)

产品号 #19854_C

未接触小鼠B细胞的免疫磁阴性分离

产品优势

  • 快速且易于使用
  • 纯度高达95%
  • 不需要列
  • 未接触的活细胞

产品组分包括

  • EasySep™小鼠B细胞分离试剂盒(目录#19854)
    • EasySep™小鼠B细胞分离试剂盒,0.5 mL
    • EasySep™Streptavidin RapidSpheres™50001,1 mL
    • EasySep™FcR小鼠阻断剂,0.2 mL
  • RoboSep™小鼠B细胞分离试剂盒(目录#19854RF)
    • EasySep™小鼠B细胞分离试剂盒,0.5 mL
    • EasySep™Streptavidin RapidSpheres™50001,1 mL
    • EasySep™FcR小鼠阻断剂,0.2 mL
    • RoboSep™缓冲器(目录#20104)
    • RoboSep™过滤器提示(目录#20125)
New format, same high quality! You may notice that your kit contents and packaging look slightly different from previous orders. We are currently updating the format of select EasySep™ Mouse kits to include a Mouse FcR blocker instead of Normal Rat Serum. With this change, all components will now be shipped in a single package, while providing the same cell isolation performance as before.
Products for Your Protocol
To see all required products for your protocol, please consult the Protocols and Documentation.

概述

使用EasySep™小鼠B细胞分离试剂盒,通过免疫磁阴性选择,从脾细胞或其他组织样品的单细胞悬浮液中轻松高效地分离高度纯化的小鼠B细胞。EasySep™在已发表的研究中广泛使用了20多年,它结合了单克隆抗体的特异性和无柱磁系统的简单性。

在这个EasySep™阴性选择程序中,用抗体复合物和磁性颗粒标记不需要的细胞。表达以下标记的不需要的细胞被靶向去除:CD11b, CD4, CD8a, Ly6G/C, Ter119, CD43, CD49b和CD90.2。然后使用EasySep™磁铁将磁性标记的细胞与未接触的所需B细胞分离,并将所需细胞倒入或移液到新管中。磁性细胞分离只需15分钟,所需的B细胞就可以用于流式细胞术、培养和基于细胞的实验等下游应用。

对于表达CD11b或CD43的B细胞的分离,我们建议使用EasySep™小鼠泛B细胞分离试剂盒(目录#19844)。

了解更多关于免疫磁性的知识EasySep™技术工作原理或如何完全自动化免疫磁细胞分离RoboSep™。探索额外的产品针对您的工作流程进行了优化,包括培养基、补充剂、抗体等。

Magnet Compatibility

• EasySep™ Magnet (Catalog #18000)
• “The Big Easy” EasySep™ Magnet (Catalog #18001)
• EasyPlate™ EasySep™ Magnet (Catalog 18102)
• EasyEights™ EasySep™ Magnet (Catalog #18103)
• RoboSep™-S (Catalog #21000)
 
Subtype
Cell Isolation Kits
 
Cell Type
B Cells
 
Species
Mouse
 
Sample Source
Other, Spleen
 
Selection Method
Negative
 
Application
Cell Isolation
 
Brand
EasySep, RoboSep
 
Area of Interest
Immunology
 

Data Figures

Typical EasySep™ Mouse B Cell Isolation Profile

Figure 1. Typical EasySep™ Mouse B Cell Isolation Profile

Starting with mouse splenocytes, the B cell content (CD19+CD3-) of the isolated fraction is 97.6 ± 1.7% (mean ± SD), using the purple EasySep™ Magnet.

EasySep™ Cell Isolation Protocol Lengths

Figure 2. EasySep™ Cell Isolation Protocol Lengths

Typical time taken (in minutes) to isolate cells using select EasySep™ kits.

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Catalog #
19854RF
Lot #
All
Language
English
Catalog #
19854
Lot #
All
Language
English
Document Type
Safety Data Sheet 1
Catalog #
19854RF
Lot #
All
Language
English
Document Type
Safety Data Sheet 2
Catalog #
19854RF
Lot #
All
Language
English
Document Type
Safety Data Sheet 3
Catalog #
19854RF
Lot #
All
Language
English
Document Type
Safety Data Sheet 4
Catalog #
19854RF
Lot #
All
Language
English
Document Type
Safety Data Sheet 5
Catalog #
19854RF
Lot #
All
Language
English
Document Type
Safety Data Sheet 1
Catalog #
19854
Lot #
All
Language
English
Document Type
Safety Data Sheet 2
Catalog #
19854
Lot #
All
Language
English
Document Type
Safety Data Sheet 3
Catalog #
19854
Lot #
All
Language
English
Document Type
Safety Data Sheet 4
Catalog #
19854
Lot #
All
Language
English

Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

Resources and Publications

Educational Materials (10)

Frequently Asked Questions

Can EasySep™ Streptavidin RapidSpheres™ be used for either positive or negative selection?

Currently, EasySep™ Streptavidin RapidSphere™ kits are only available for negative selection and work by targeting and removing unwanted cells.

How does the separation work?

Streptavidin RapidSphere™ magnetic particles are crosslinked to unwanted cells using biotinylated antibodies. When placed in the EasySep™ Magnet, labeled cells migrate to the wall of the tube. The unlabeled cells are then poured off into a new tube.

Which columns do I use?

The EasySep™ procedure is column-free. That's right - no columns!

How can I analyze the purity of my enriched sample?

The Product Information Sheet provided with each EasySep™ kit contains detailed staining information.

Can EasySep™ Streptavidin RapidSphere™ separations be automated?

Yes. RoboSep™, the fully automated cell separator, automates all EasySep™ labeling and cell separation steps.

Are cells isolated using EasySep™ RapidSphere™ products FACS-compatible?

Yes. Desired cells are unlabeled and ready to use in downstream applications, such as FACS analysis.

Can I alter the separation time in the magnet?

Yes; however, this may impact the kit's performance. The provided EasySep™ protocols have already been optimized to balance purity, recovery and time spent on the isolation.

Publications (37)

Co-modulation of T cells and B cells enhances the inhibition of inflammation in experimental hypersensitivity pneumonitis. O. Courtemanche et al. Respiratory research 2022 oct

Abstract

BACKGROUND Hypersensitivity pneumonitis (HP) is an interstitial lung disease characterized by antigen-triggered neutrophilic exacerbations. Although CD4+ T cells are sufficient for HP pathogenesis, this never translated into efficient T cell-specific therapies. Increasing evidence shows that B cells also play decisive roles in HP. Here, we aimed to further define the respective contributions of B and T cells in subacute experimental HP. METHODS Mice were subjected to a protocol of subacute exposure to the archaeon Methanosphaera stadmanae to induce experimental HP. Using models of adoptive transfers of B cells and T cells in Rag1-deficient mice and of B cell-specific S1P1 deletion, we assessed the importance of B cells in the development of HP by evaluating inflammation in bronchoalveolar lavage fluid. We also aimed to determine if injected antibodies targeting B and/or T cells could alleviate HP exacerbations using a therapeutic course of intervention. RESULTS Even though B cells are not sufficient to induce HP, they strongly potentiate CD4+ T cell-induced HP?‘associated neutrophilic inflammation in the airways. However, the reduction of 85% of lung B cells in mice with a CD19-driven S1P1 deletion does not dampen HP inflammation, suggesting that lung B cells are not necessary in large numbers to sustain local inflammation. Finally, we found that injecting antibodies targeting B cells after experimental HP was induced does not dampen neutrophilic exacerbation. Yet, injection of antibodies directed against B cells and T cells yielded a potent 76% inhibition of neutrophilic accumulation in the lungs. This inhibition occurred despite partial, sometimes mild, depletion of B cells and T cells subsets. CONCLUSIONS Although B cells are required for maximal inflammation in subacute experimental HP, partial reduction of B cells fails to reduce HP-associated inflammation by itself. However, co-modulation of T cells and B cells yields enhanced inhibition of HP exacerbation caused by an antigenic rechallenge.
Immune correlates of protection following Rift Valley fever virus vaccination. J. D. Doyle et al. NPJ vaccines 2022 oct

Abstract

Rift Valley fever virus (RVFV) is a hemorrhagic fever virus with the potential for significant economic and public health impact. Vaccination with an attenuated strain, DelNSsRVFV, provides protection from an otherwise lethal RVFV challenge, but mechanistic determinants of protection are undefined. In this study, a murine model was used to assess the contributions of humoral and cellular immunity to DelNSsRVFV-mediated protection. Vaccinated mice depleted of T cells were protected against subsequent challenge, and passive transfer of immune serum from vaccinated animals to na{\{i}}ve animals was also protective demonstrating that T cells were dispensable in the presence of humoral immunity and that humoral immunity alone was sufficient. Animals depleted of B cells and then vaccinated were protected against challenge. Total splenocytes but not T cells alone B cells alone or B??+??T cells harvested from vaccinated animals and then transferred to na{\"{i}}ve animals were sufficient to confer protection suggesting that multiple cellular interactions were required for effective cellular immunity. Together these data indicate that humoral immunity is sufficient to confer vaccine-mediated protection and suggests that cellular immunity plays a role in protection that requires the interaction of various cellular components."
Pre-Germinal Center Interactions with T Cells Are Natural Checkpoints to Limit Autoimmune B Cell Responses. K. A. Parham et al. Journal of immunology (Baltimore, Md. : 1950) 2022 nov

Abstract

Interactions with Ag-specific T cells drive B cell activation and fate choices that ultimately determine the quality of high-affinity Ab responses. As such, these interactions, and especially the long-lived interactions that occur before germinal center formation, may be important checkpoints to regulate undesirable responses. Using mouse model Ag systems, we directly observed interactions between T and B cells responding to the self-antigen myelin oligodendrocyte glycoprotein (MOG) and found that they are of lower quality compared with interactions between cells responding to the model foreign Ag nitrophenyl-haptenated OVA. This was associated with reduced expression of molecules that facilitate these interactions on the B cells, but not on T cells. B cell expression of these molecules was not dictated by the T cell partner, nor could the relative lack of expression on MOG-specific (MOG-sp.) B cells be reversed by a multivalent Ag. Instead, MOG-sp. B cells were inherently less responsive to BCR stimulation than MOG-non-sp. cells. However, the phenotype of MOG-sp. B cells was not consistent with previous descriptions of autoimmune B cells that had been tolerized via regular exposure to systemically expressed self-antigen. This suggests that alternate anergy pathways may exist to limit B cell responses to tissue-restricted self-antigens.

更多信息

更多信息
Species Mouse
Magnet Compatibility • EasySep™ Magnet (Catalog #18000) • “The Big Easy” EasySep™ Magnet (Catalog #18001) • EasyPlate™ EasySep™ Magnet (Catalog 18102) • EasyEights™ EasySep™ Magnet (Catalog #18103) • RoboSep™-S (Catalog #21000)
Sample Source Other, Spleen
Selection Method Negative
PRODUCTS ARE FOR RESEARCH USE ONLY AND NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED. FOR ADDITIONAL INFORMATION ON QUALITY AT STEMCELL, REFER TO WWW.STEMCELL.COM/COMPLIANCE.
版权 © 2025 STEMCELL Technologies 技术有限公司。保留所有权利。